These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9607738)

  • 1. Hyperhomocysteinemia is a risk factor for venous and arterial thrombosis.
    Makris M
    Br J Haematol; 1998 May; 101 Suppl 1():18-20. PubMed ID: 9607738
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine and venous thrombosis.
    Quéré I; Gris JC; Dauzat M
    Semin Vasc Med; 2005 May; 5(2):183-9. PubMed ID: 16047270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Homocystinuria: case reports with a note on hyperhomocysteinemia as a risk factor for the early onset of vascular disease].
    Barić I; Barisić N; Blau N; Mardesić D
    Lijec Vjesn; 1994; 116(7-8):188-91. PubMed ID: 7853996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia, atherosclerosis and thrombosis.
    Cattaneo M
    Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia and thrombosis.
    Makris M
    Clin Lab Haematol; 2000 Jun; 22(3):133-43. PubMed ID: 10931161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.
    de Souza AW; Silva NP; de Carvalho JF; D'Almeida V; Noguti MA; Sato EI
    Lupus; 2007; 16(10):782-7. PubMed ID: 17895300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: a case report.
    Costea A; Bhat G
    Am J Hematol; 2004 Oct; 77(2):161-3. PubMed ID: 15389901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
    den Heijer M; Rosendaal FR; Blom HJ; Gerrits WB; Bos GM
    Thromb Haemost; 1998 Dec; 80(6):874-7. PubMed ID: 9869152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis.
    Keijzer MB; den Heijer M; Borm GF; Blom HJ; Vollset SE; Hermus AR; Ueland PM
    Thromb Haemost; 2006 Oct; 96(4):492-7. PubMed ID: 17003928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperhomocysteinemia, atherosclerosis and arterial and venous thrombosis].
    Cacoub P; Gatel A; Sbai A; Piette JC; Godeau P
    Ann Med Interne (Paris); 1996; 147(5):352-60. PubMed ID: 9033740
    [No Abstract]   [Full Text] [Related]  

  • 12. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and thrombosis: from basic science to clinical evidence.
    Undas A; Brozek J; Szczeklik A
    Thromb Haemost; 2005 Nov; 94(5):907-15. PubMed ID: 16363230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cysteine and homocysteine in venous and arterial thrombotic disease.
    Marcucci R; Brunelli T; Giusti B; Fedi S; Pepe G; Poli D; Prisco D; Abbate R; Gensini GF
    Am J Clin Pathol; 2001 Jul; 116(1):56-60. PubMed ID: 11447752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin.
    Perna AF; Castaldo P; Ingrosso D; De Santo NG
    J Nephrol; 1999; 12(4):230-40. PubMed ID: 10493566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels.
    Lijfering WM; Veeger NJ; Brouwer JL; van der Meer J
    Haematologica; 2007 Dec; 92(12):1703-6. PubMed ID: 18055997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperhomocysteinemia--a new risk factor for vascular diseases?].
    Brattström L; Israelsson B; Hultberg B
    Lakartidningen; 1992 Feb; 89(7):467-9. PubMed ID: 1738269
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.